[Review on gene polymorphisms of UDP-glucuronosyltransferases and genetic susceptibility of cancer]
- PMID: 19069670
[Review on gene polymorphisms of UDP-glucuronosyltransferases and genetic susceptibility of cancer]
Abstract
UDP-glucuronosyltransferases (UGT) are important phase II metabolizing enzymes that catalyse the glucuronidation of numerous endobiotics and xenobiotics. Several human hepatic and extrahepatic UGT isozymes have been characterized with respect to their substrate specificity, tissue expression and gene structure. Genetic polymorphisms have been identified for almost all the UGT family members. Some Polymorphisms of UGT gene had an effect on the activity of UGT enzymes, then influenced the glucuronidation against cancer-related substrates, ultimately affected the genetic toxicity and carcinogenesis induced by cancer-related substrates. Numerous studies reported that polymorphisms of UGT gene were associated with the risk of several kinds of cancer, such as colorectal cancer, breast cancer, lung cancer, proximal digestive tract cancer, hepatocellular carcinoma and prostate cancer. This review examines in detail each UGT isozyme known to be associated with cancer.
Similar articles
-
Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer.Oncogene. 2006 Mar 13;25(11):1659-72. doi: 10.1038/sj.onc.1209375. Oncogene. 2006. PMID: 16550166 Review.
-
Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases.Methods Enzymol. 2005;400:104-16. doi: 10.1016/S0076-6879(05)00007-8. Methods Enzymol. 2005. PMID: 16399346 Review.
-
Genetic polymorphisms of human UDP-glucuronosyltransferase (UGT) genes and cancer risk.Drug Metab Rev. 2016;48(1):47-69. doi: 10.3109/03602532.2015.1131292. Epub 2016 Feb 1. Drug Metab Rev. 2016. PMID: 26828111 Review.
-
UGT pharmacogenomics: implications for cancer risk and cancer therapeutics.Pharmacogenetics. 2003 Aug;13(8):517-23. doi: 10.1097/01.fpc.0000054116.14659.e5. Pharmacogenetics. 2003. PMID: 12893990
-
Polymorphisms of the carcinogen detoxifying UDP-glucuronosyltransferase UGT1A7 in proximal digestive tract cancer.Z Gastroenterol. 2002 Jul;40(7):497-502. doi: 10.1055/s-2002-32805. Z Gastroenterol. 2002. PMID: 12122597